Feb 6, 2026
What are the full hematologic monitoring schedules (CBC frequency and stopping rules) used in registered mebendazole oncology trials (NCT01729260, NCT01837862, NCT03628079)?
The public record for the three contains explicit hematologic toxicity definitions for the adult high‑grade glioma Phase I trial () but does not publish a complete, day‑by‑day CBC monitoring schedule ...